Cargando…
A dual-specific IGF-I/II human engineered antibody domain inhibits IGF signaling in breast cancer cells
The insulin-like growth factors (IGFs), IGF-I and IGF-II, are essential for regulating cell growth, differentiation and metastasis of a broad range of malignancies. The IGF-I/II actions are mediated through the IGF receptor type 1 (IGF-1R) and the insulin receptor (IR), which are overexpressed in mu...
Autores principales: | Chen, Zhizhen, Liu, Jie, Chu, Dafeng, Shan, Yaming, Ma, Guixing, Zhang, Hongmin, Zhang, Xiaohua Douglas, Wang, Pu, Chen, Qiang, Deng, Chuxia, Chen, Weizao, Dimitrov, Dimiter S., Zhao, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001679/ https://www.ncbi.nlm.nih.gov/pubmed/29910690 http://dx.doi.org/10.7150/ijbs.25928 |
Ejemplares similares
-
Antibody-based therapeutics against components of the IGF system
por: Feng, Yang, et al.
Publicado: (2012) -
The Antibody Germline/Maturation Hypothesis, Elicitation of Broadly Neutralizing Antibodies Against HIV-1 and Cord Blood IgM Repertoires
por: Prabakaran, Ponraj, et al.
Publicado: (2014) -
Human Domain Antibodies to Conserved Epitopes on HER2 Potently Inhibit Growth of HER2-Overexpressing Human Breast Cancer Cells In Vitro
por: Wang, Hongqian, et al.
Publicado: (2019) -
OR17-3 Cartilage-Targeted IGF-1 Treatment to Promote Longitudinal Bone Growth
por: Lui, Julian, et al.
Publicado: (2019) -
Maturation Pathways of Cross-Reactive HIV-1 Neutralizing Antibodies
por: Xiao, Xiaodong, et al.
Publicado: (2009)